Unilever (UL) is considering a bid for Thorne, a South Carolina-based company that sells dietary supplement pills, valued at up to $4 billion, the Financial Times reported Friday, citing people familiar with the matter.
Several other companies are exploring a potential deal for Thorne, which has been put up for sale by its private equity owner L Catterton, the report said.
Unilever and Thorne did not immediately respond to MT Newswires' requests for comment.
(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
Comments